"There's a way to do it better ��find it." ��Thomas Edison
Open any Berkshire Hathaway (BRK.A)(BRK.B) annual letter and the first thing you see will be a listing of the yearly gains in the book value per share of BRK.A from 1965 to the present year. At the bottom of the year-by-year synopsis lies the compounded annual growth rate (CAGR) of those gains in equity. Later in the article I will show the mathematical formula for calculating those compound gains.
Buffett believes that gains in book value per share are a better reflection of the growth in value of BRK.A as opposed to gains in the price per share of the company. Buffett uses book value as opposed to price per share since he feels that the market does not always assign a fair valuation to his company. He then compares changes in the equity of BRK.A to changes in the value of the S&P index while adding back in dividends.
This is Buffett's acid test for evaluating his efficiency in allocating capital at Berkshire Hathaway. After all, if the gains in the equity of his company were not significantly superior to gains in the S&P plus the dividends which they accrue, why would any sane individual choose to invest in BRK.A instead of an S&P index fund?
Top Cheap Stocks To Buy Right Now: Osiris Therapeutics Inc.(OSIR)
Osiris Therapeutics, Inc., a stem cell company, focuses on the development and marketing of therapeutic products to treat various medical conditions in the inflammatory, autoimmune, orthopedic, and cardiovascular areas. It operates in two business segments, Therapeutics and Biosurgery. The Therapeutics segment focuses on developing biologic stem cell drug candidates from a readily available and non-controversial source, adult bone marrow. The Biosurgery segment works to harness the ability of cells and novel constructs to promote the body's natural healing. This segment focuses on developing biologic products for use in surgical procedures. The company?s lead biologic drug candidate is Prochymal, which is in phase 2 and 3 clinical trails for various indications, including acute graft versus host disease (GvHD), Crohn's disease, acute myocardial infarction, type 1 diabetes, pulmonary disease, and gastrointestinal injury resulting from radiation exposure. Its biologic drug candidates also include Chondrogen, a preparation of adult mesenchymal stem cells that is in phase 2 clinical trials for osteoarthritis and cartilage protection. The company has collaboration agreements with Genzyme Corporation for the development and commercialization of Prochymal and Chondrogen in various countries except in the United States and Canada. It also has a partnership with Juvenile Diabetes Research Foundation for the development of Prochymal as a treatment for the preservation of insulin production in patients with newly diagnosed type 1 diabetes mellitus. Osiris Therapeutics, Inc. was founded in 1992 and is headquartered in Columbia, Maryland.
Advisors' Opinion:- [By Lauren Pollock]
Osiris Therapeutics Inc.(OSIR) said Friday a proposed ruling from the Centers for Medicare and Medicaid Services won’t immediately affect reimbursements for its Grafix stem-cell product. The regenerative medicine company said Grafix will maintain its current reimbursement status — also called transitional pass-through status — potentially through late 2015.
- [By Maxx Chatsko]
Additionally, stem cell therapies have remained elusive as the industry's ultimate Holy Grail. Osiris (NASDAQ: OSIR ) received Canadian approval for the world's first stem cell drug, Prochymal, for children battling acute graft-versus-host disease, or GvHD, last year. The approval meant more symbolically than to the bottom line, but it definitely put the potential of stem cells front and center for investors.
Hot High Tech Companies For 2014: LHC Group Inc (LHCG)
LHC Group, Inc. (LHC Group), incorporated on January 1, 2005, provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals (LTACHs). As of December 31, 2012, through the Company's wholly- and majority-owned subsidiaries, equity joint ventures and controlled affiliates, the Company operated in Alabama, Arkansas, Florida, Georgia, Idaho, Kentucky, Louisiana, Maryland, Mississippi, Missouri, North Carolina, Ohio, Oklahoma, Oregon, Tennessee, Texas, Virginia, West Virginia and Washington. The Company operates in two segments: home-based services and facility-based services. As of December 31, 2012, the Company owned and operated 274 home-based service locations, with 232 home nursing agency locations, 32 hospices, three specialty agencies and four private duty agencies. In February 2014, LHC Group Inc acquired two home health providers.
As of December 31, 2012, the Company also managed the operations of three home nursing agencies in which the Company does not have an ownership interest. The Company's facility-based services included six long-term acute care hospitals with nine locations, a pharmacy, and a family health center. The Company provides home-based post-acute health care services through its home nursing agencies and hospices. The Company's home nursing locations offer a wide range of services, including skilled nursing, medically-oriented social services and physical, occupational and speech therapy. The nurses, home health aides and therapists in the Company's home nursing agencies work closely with patients and their families to design and implement individualized treatments in accordance with a physician-prescribed plan of care.
The Company's hospices provide end-of-life care to patients with terminal illnesses through interdisciplinary teams of physicians, nurses, home health aides, counselors and volunteers. Of the 274 home-based services locations, 140 are wholly-owned by the Company, 124 ar! e majority-owned or controlled by the Company through joint ventures, seven are operated through license lease arrangements, and the Company manages the operations of three home nursing agencies in which the Company has no ownership interest.
The Company's LTACH locations provide services primarily to patients with complex medical conditions who have transitioned out of a hospital intensive care unit but whose conditions remain too severe for treatment in a non-acute setting. As of December 31, 2012, the Company's LTACHs had 220 licensed beds. Of the Company's 11 facility-based services locations, six are wholly-owned by the Company and five are majority-owned or controlled by the Company through joint ventures.
Home-Based Services
The Company�� registered and licensed practical nurses provide a range of medically necessary services to homebound patients who are suffering from acute or chronic illness, recovering from injury or surgery, or who otherwise require care, teaching or monitoring. These services include wound care and dressing changes; cardiac rehabilitation; infusion therapy; pain management; pharmaceutical administration; skilled observation and assessment, and patient education. It has also designed guidelines to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer�� disease, low vision, spinal stenosis, Parkinson�� disease, osteoporosis, complex wound care and chronic pain. Its home health aides provide assistance with daily living activities, such as light housekeeping, simple meal preparation, medication management, bathing and walking. Through its medical social workers, it counsels patients and their families with regard to financial, personal and social concerns that arise from a patient�� health-related problems.
The Company provides skilled nursing, ventilator and tracheotomy services, extended care specialties, medication administration and management, and patient and family assistance an! d educati! on. It also provides management services to third-party home nursing agencies, often as an interim solution until proper state and regulatory approvals for an acquisition can be obtained. The Company�� physical, occupational and speech therapists provide therapy services to patients in their home. Its therapists coordinate multi-disciplinary treatment plans with physicians, nurses and social workers to restore basic mobility skills, such as getting out of bed and walking safely with crutches or a walker. Its therapists assist patients and their families with improving and maintaining a patient�� ability to perform functional activities of daily living, such as the ability to dress, cook, clean and manage other activities safely in the home environment. Its speech and language therapists provide corrective and rehabilitative treatment to patients who suffer from physical or cognitive deficits or disorders that create difficulty with verbal communication or swallowing.
All of the Company�� home nursing agencies offer 24-hour personal emergency response and support services through Philips Lifeline (Lifeline) for qualified patients who require close medical monitoring but who want to maintain an independent lifestyle. These services consist principally of a communicator that connects to the telephone line in the subscriber�� home and a personal help button that is worn or carried by the individual subscriber which, when activated, initiates a telephone call from the subscriber�� communicator to Lifeline�� central monitoring facilities. Lifeline�� trained personnel identify the nature and extent of the subscriber�� particular need and notify the subscriber�� family members, neighbors and/or emergency personnel, as needed.
The Company�� Medicare-certified hospice operations provide a range of hospice services designed to meet the individual physical, spiritual and psychosocial needs of terminally ill patients and their families. Its hospice services are primaril! y provide! d in a patient�� home but can also be provided in a nursing home, assisted living facility or hospital. Key services provided include pain and symptom management accompanied by palliative medication, emotional and spiritual support, spiritual counseling and family bereavement counseling, inpatient and respite care, homemaker services, dietary counseling and social worker visits for up to 13 months after a patient�� death.
Facility-Based Services
The Company�� LTACHs treat patients with severe medical conditions who require a care and frequent monitoring by physicians and other clinical personnel. Patients who receive its services in an LTACH are too medically unstable to be treated in a non-acute setting. It also treats patients diagnosed with musculoskeletal impairments that restrict their ability to perform normal activities of daily living. As part of its facility-based services, the Company operates an institutional pharmacy, which focuses on providing a full array of services to its long-term acute care hospitals. All coding, medical records, case management, utilization review and medical staff credentialing are provided at the hospital level. Centralized functions that are provided by the home office include payroll, accounting, financial reporting, billing, collections, regulatory and legal compliance, risk management, pharmacy, information technology and general clinical oversight accomplished by periodic on-site surveys.
Advisors' Opinion:- [By Sean Williams]
What: Shares of home health providers Amedisys (NASDAQ: AMED ) , Gentiva Health Services (NASDAQ: GTIV ) , and�LHC Group (NASDAQ: LHCG ) �swooned as much as 28%, 20%, and 15%, respectively, following a public proposal by the Centers for Medicare and Medicaid Services, or CMS, late yesterday that in-home health care reimbursements be cut by 1.5% in 2014.
Hot High Tech Companies For 2014: SINOPEC Shangai Petrochemical Company Ltd.(SHI)
Sinopec Shanghai Petrochemical Company Limited engages in the production of polypropylene compound products, polypropylene products, acrylic fiber products, petrochemical products, synthetic fibers, resins and plastics, and petroleum products in China and internationally. It also involves in the import and export of petrochemical products and equipment. The company was founded in 1972 and is based in Shanghai, the People's Republic of China. Sinopec Shanghai Petrochemical Company Limited is a subsidiary of China Petroleum & Chemical Corporation.
Advisors' Opinion:- [By Dan Caplinger]
Chesapeake is still seeking to raise more cash through further asset sales this year. In February, Chesapeake sold a 50% interest in some of its Mississippi Lime acreage to China's Sinopec (NYSE: SHI ) . Then, earlier this month, Chesapeake said it's looking to sell further acreage in the Utica Shale play in the U.S. Midwest. Motley Fool contributor Tyler Crowe believes that Chevron (NYSE: CVX ) might be a natural buyer for Chesapeake's Utica property, given its recent commitment to focusing on unconventional domestic energy plays for further growth.
Hot High Tech Companies For 2014: Hospitality Properites Trust (HPT)
Hospitality Properties Trust, a real estate investment trust (REIT), engages in buying, owning, and leasing hotels. The company�s hotels are operated as Courtyard by Marriott, Residence Inn by Marriott, Staybridge Suites by Holiday Inn, Candlewood Suites, AmeriSuites, Prime Hotels and Resorts, Homestead Studio Suites, TownePlace Suites by Marriott, and SpringHill Suites by Marriott or Marriott Hotels and Resorts. As of June 30, 2005, it owned 298 hotels located in 38 states in the United States; Puerto Rico; and Ontario, Canada. The company�s hotels are primarily designed for business, governmental, and family travelers. As a REIT, the company would not be subject to federal income tax provided it distributes at least 90% of its REIT taxable income to its stockholders. Hospitality Properties was formed in 1995 and is based in Newton, Massachusetts.
Advisors' Opinion:- [By Russ Krull]
Hospitality Properties (NYSE: HPT ) sold $300 million of 10-year, 4.25% paper to fund the redemption of 7% preferred shares.�There are 6.7 million preferred shares at $25 each for total of $167.5 million.�The new debt service will cost about $1 million more per year than the preferred dividends, but Hospitality is getting quite a bit of additional cash for "funding hotel renovation or rebranding costs and potential future acquisitions."
- [By Marc Bastow]
Hotel and travel REIT Hospitality Properties Trust (HPT) raised its quarterly dividend 2.1% to 48 cents per share, payable Nov. 22 to shareholders of record as of Oct. 25.
HPT Dividend Yield: 6.71%
No comments:
Post a Comment